Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.122ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAJENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.431ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.168ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.6 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.343ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.17 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.25.1.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.409ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Y.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
AY.43.6 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.9 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.256ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.248ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.559ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.7 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.460ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.262ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used